The Turkish Association of Research-Based Pharmaceutical Companies’ (AFID) “Vision 2023” report released earlier this month recommends ways to make the country among the top 10 countries in health services by 2023. Turkey’s pharmaceutical market was valued at $11.2 billion in 2011, ranking 16th in the world. However, in 2011, Turkey’s 70 clinical trials supported by […]

The Chinese State Food and Drug Administration’s (SFDA) new GMP regulations could result in a restructure of the country’s drug industry. In March 2011, the SFDA announced new GMP regulations, which firms must adhere to by December 2015. Chinese drug exports conform to European, US and Japanese regulations, so Chinese firms that export active pharmaceutical […]

In 2011, China’s oil and chemical industry’s gross output value grew 31.5% to CNY 11.3 trillion ($1.7 trillion). The industry’s gross output value of imports and exports rose 32.3% to $607 billion. The China Petroleum and Chemical Industry Federation forecasts industry output to grow 14.5% in 2012, with profits rising 5% to CNY 860 billion. […]

Sweden’s Research and Innovation Bill will provide SEK 11.5 billion ($1.7 billion) in additional funds from 2013 to 2016, expanding funding from SEK 1.7 billion in 2013 to SEK 4.0 billion in 2016. Universities, the life sciences, research for new products and services, and research facilities will receive SEK 4.3 billion, SEK 2.1 billion, SEK […]

India’s INR 60,000 crore ($11 billion) drug market is growing 17%–20% annually, but domestic drug companies face new challenges to their businesses. The country’s National Pharmaceutical Pricing Policy has announced new price reductions for 276 drugs, which is expected to affect margins for both local and international drug makers. In addition, reductions in income taxes […]